1/ Just looked @ CDC's AZ school-mask study. What a load of garbage. Here’s why:
-No info on actual # of cases, or # of kids in school
-No info on testing levels
-52% of schools WITH mask reqs were small (<850) vs. 13% in No-Mask Schools
-Case rates 2.4x in no-Mask Areas
2/ When numbers are missing, it tells you something. The key number here SHOULD be, number of cases/child. That they chose outbreaks instead is...fishy. That 52% of masked schools were small, vs. 13% of un-masked, is important. Fewer kids in schools = Outbreak less likely.
3/ It's kind of amazing they needed to do this. The CDC basically set its "close contact" rules for schools to "prove" masks work.
In situations where both kids are masked, a masked contact DOESN'T count as a contact, AND THUS DOESN'T NEED TO BE TESTED. cdc.gov/coronavirus/20…
4/ The same sleight of hand is also being used to depress vaxed case numbers, as vaxed "close contacts" don't need to be tested.
5/ To re-cap we are missing the most important information here: total cases/total students. We also have a system rigged to favor masking as masked close contacts kids DON'T need to test. AND un-masked schools R much larger. This study stinks to high heaven of data manipulation.
6/ Once I saw the CDC guidance on exempting masked close contacts, I KNEW they would be using this to manipulate the data. What surprised me is that even with this leg-up, they still had to resort to even further manipulation. (link to study here) cdc.gov/mmwr/volumes/7…
• • •
Missing some Tweet in this thread? You can try to
force a refresh
3/ This applies to hospitalizations, too. And one must also remember than in May, the CDC told hospitals to stop testing fully-vaxed people, unless there explicitly FOR COVID.
3/ I do think that the mask mandates are being kept in place to ⬆️ child vax uptake. B/c cdc knows parents want kids unmasked, is this supposedly benign intervention to encourage a better future outcome causing them to be willfully blind to potential harms?
1/ The overall effects of this study are miniscule—0.07% absolute reduction in seroprevalence. But the topline finding is “We decreased seroprevalence by 10%!”
Technically true...
But even this finding is questionable. Let's explore.
2/2/
What the study ACTUALLY measures is the impact of mask promotion on symptom reporting. Only if a person reports symptoms, are they asked to participate in a serology study—and only 40% of those with symptoms chose to have their blood taken.
3/ Is it possible that that highly moralistic framing and monetary incentives given to village elders for compliance might dissuade a person from reporting symptoms representing individual and collective moral failure—one that could cost the village money? Maybe?
1/ Trying to mask the abject failure of blue state COVID responses, a new success metric has been rolled out: Vax levels. But whole pop. vax levels, mask much lower variance in at-risk groups. What's more, deaths in 65+ from Jan-Jun are NOT linked to vax levels.
2/
Some will say that the vaccination level of the population is important b/c those other vaccinations are shielding the at-risk further. But excess deaths since January are NOT tied to higher levels of whole population vaccination.
4/ The push to vax well beyond the at-risk represents another installment of “following the science” where sadly, fealty to “the science” does not produce any measurable result. This new metric—whole pop. Vax—is designed to wash away all the other failures docs.google.com/spreadsheets/d…
1/ The proof (long-suspected) that the mRNA (like AZ DNA) vaxes do not offer sterilizing immunity is now being used to push wider vaccination among kids to acquire “herd immunity.” This makes no sense—it should be the opposite. wsj.com/articles/vacci…
2/ AZ is the only manufacturer that did weekly testing of trial participants to evaluate the efficacy of vaccines in stopping infection—not just disease. These results showed that the AZ standard dose had no impact on reducing asymptomatic infection.
3/ Neither Pfizer’s nor Moderna’s trials did this. Pfizer’s recorded 170 infections (162 control v. 8 vax) However, data in the FDA’s review showed an additional 3410 suspected cases—1816 control/1594 vax. This would reduce efficacy from 95% to 19%. blogs.bmj.com/bmj/2021/01/04…